Journals / Medicine Science / 2016 / Cilt: 5 - Sayı: 1

The Effect of Dexamethasone in Tramadol Induced Nausea and Vomiting

Pages
94–101
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that a single bolus dose of dexamethasone 8 mg has not reduced tramadol induced nausea and vomiting in patients who were planned to undergo TAH

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to investigate the efficacy of a single dose bolus of dexamethasone on tramadol induced nausea and vomiting in our study.
📊
Key Findings & Data:After approval was taken from ethics committee and patients, a total of 60 ASA I-II patients who were planned to undergo total abdominal hysterectomy (TAH) under general anesthesia were included in this study.
💡
Conclusion & Impact:It was concluded that a single bolus dose of dexamethasone 8 mg has not reduced tramadol induced nausea and vomiting in patients who were planned to undergo TAH
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We aimed to investigate the efficacy of a single dose bolus of dexamethasone on tramadol induced nausea and vomiting in our study. After approval was taken from ethics committee and patients, a total of 60 ASA I-II patients who were planned to undergo total abdominal hysterectomy (TAH) under general anesthesia were included in this study. A patient-controlled analgesia device was explained for the patients with preoperative visit. After the non-premedicated patients were taken in the operation room, the routine monitorization was performed. Induction was provided with 1μg/kg of fentanyl, 2 mg/kg propofol and 0.1 mg/kg vecuronium. 6-8% concentration of desflurane in a mixture of 50% air and 50% O2 was used for maintenance of anesthesia. When the incision was started to be closed, the patients were randomized into two groups by envelope method. 8 mg iv dexamethasone (2 mL) was given for Group D (n=30), iv Saline solution (2 mL) was given for Group K (n=30). After the incision was closed, a loading dose of intravenous tramadol 1 mg/kg was administered in both groups. The patients were taken in the postanesthesia care unit by extubating following the antagonism of muscle relaxant at the end of surgery. The patient-controlled analgesia device was scheduled to be as infusion: no, bolus: 12 mg, lock-out time: 10 min, 24 hour dosing limit: 400 mg. The pain and nausea and vomiting scores, additional analgesic and antiemetic requirements, the total amount of tramadol consumption were recorded at post-operative recovery and postoperative 2, 4, 6, 12 and 24 hours. Although the incidence of nausea and vomiting, and pain scores at 2 and 4 hours were not statistically significant, they were lower in Gorup D compared to Group K (p>0.05). 14 patients in Group K required additional antiemetics and 12 patients in Group D required additional antiemetics (p>0.05). Six patients in Group K required additional analgesics and 4 patients in Group D required additional analgesics. Although the total amount of tramadol consumption was not statistically significant, it was lower in Group D compared to Group K. It was concluded that a single bolus dose of dexamethasone 8 mg has not reduced tramadol induced nausea and vomiting in patients who were planned to undergo TAH

🔖

Cite This Article

GÜLHAŞ, N., ŞANLI, M., ASLAN, A. V., ÖZGÜL, Ü., BİCAKCİOGLU, M., DURMUŞ, M. (2016). The Effect of Dexamethasone in Tramadol Induced Nausea and Vomiting. Medicine Science, Cilt: 5 - Sayı: 1, 94–101. https://ajindex.com/articles/277682

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Pavlin DJ, Chen C, Penaloza DA, Polissar NL, Buckley FP. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth Analg. 2002;95:627-34
  2. Mizuno J, Morita S, Hanaue N, Hanaoka K, Yokoyoma T. Intravenous patientcontrolled analgesia (IV-PCA) for relief of postoperative pain. Masui. 2011;60:908-12
  3. Lee SH, Kim KH, Cheong SM, Kim S, Kooh M, Chin DK. A comparison of the effect of epidural patient-controlled analgesia with intravenous patient-controlled analgesia on pain control after posterior lumbar instrumented fusion. Korean Neorosurg Soc. 2011;50:205-8
  4. Karaman S, Karaman T, Doğru S, Şahin A, Hakan T, Süren M, Kaya Z, Arıcı S. Postoperatif hasta kontrollü analjezide tramadol ve morfinin etkinliğinin karşılaştırılması: retrospektif çalışma. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi. 2014;6:110-8
  5. Gürses E, Serin S, Tomatır E, Balcı C, Gönüllü M. Tramadole bağlı bulantı kusmayı önlemede metoklopramid, droperidol ve ondansetronun karşılaştırılması. Kocatepe Tıp Dergisi. 2003;2:23-8
  6. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60:139-76
  7. Pang W, Liu YC, Maboudou E, Chen TX, Chois JM, Liao CC, Wu RS. Metoclopramide improves the quality of tramadol PCA indistinguishable to morphine PCA: aprospective, randomized, double blind clinical comparison. Pain Medicine. 2013;14:1426-34
  8. Jia DL, Ni C, Xu T, Zhang LP, Guo XY. A small-dose naloxone infusion alleviates nausea and sedation without impacting analgesia via intravenous tramadol. Chin Med J. 2010;123:1695-8
  9. Zheng LH, Sun H, Wang GN, Liang J, Wu HX. Effect of transcutaneous electrical acupoint stimulation on nausea and vomiting induced by patient controlled intravenous analgesia with tramadol. Chin J Integr Med. 2008;14:61-4
  10. Vale C, Oliveria F, Assuncao J, Fontes-Ribeiro C, Pereira F. Co-administration of ondansetron decreases the analgesic efficacy of tramadol in humans. Pharmacology. 2011;88:182-7
  11. Çekmen N, Akçabay M, Mahlı A, Arslan M. Postoperatif bulantı kusmada deksametazon ve metoklopramidin etkilerinin karşılaştırılması. Erciyes Tıp Dergisi. 2003;25:137-43
  12. Sekhavat L, Davar R, Behdad S. Efficacy of prophylactic dexamethasone in prevention of postoperative nausea and vomiting. J Epidemiol Glob Health. 2015;5:175-9
  13. Aşcı H, Özer MK. Bulantı ve Kusma için tedavi önerileri. SDÜ Sağlık Bilimleri Enstitüsü Dergisi. 2011;2:160-5
  14. Van den Berg AA, Halliday E, Lule EK, Baloch MS. The effects